Search research articles
Contact Us
Filters
Showing results (121-130 of 281) with videos related to
Page
of 29
Sort By:
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|
December 27, 2007
[MicroRNAs can be expressed in cardiomyocyte-like cells differentiated from human mesenchymal stem cells]
Zhi-xin Shan, Qiu-xiong Lin, Xi-yong Yu, et al.
European Journal of Pharmacology
|
August 13, 2021
A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC)
Hai-Yu Shen, Xiao-Qiang Li, Wen-Qiang Fan, et al.
Journal for Immunotherapy of Cancer
|
April 6, 2021
Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy
Chao Zhang, Kai Yin, Si-Yang Liu, et al.
Mikrochimica Acta
|
April 22, 2025
Development of an ultrasensitive magnetic bead-based non-competitive chemiluminescent immunoassay for 17β-estradiol in milk
Yi-Xian Liu, Bao-Zhu Jia, Xu-Chao Zhang, et al.
Plos One
|
October 12, 2012
A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy
Xu Chao, Zhuoli Zhang, Lili Guo, et al.
Nanoscale Advances
|
January 6, 2023
A nanofiber hydrogel derived entirely from ocean biomass for wound healing
Tian-Cai Sun, Bing-Yu Yan, Xu-Chao Ning, et al.
Journal of Cancer Research and Clinical Oncology
|
July 15, 2022
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes
Chang Lu, Xue-Wu Wei, Yi-Chen Zhang, et al.
Plos One
|
March 5, 2016
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines
Xiao-Yan Bai, Xu-Chao Zhang, Su-Qing Yang, et al.
JTO Clinical and Research Reports
|
July 5, 2022
Characteristics of and Treatment Strategies for Advanced <i>EGFR</i>-Mutant NSCLC With Concomitant <i>BRAF</i> Variations
Xue-Wu Wei, Jia-Yi Deng, Chong-Rui Xu, et al.
Journal of Hematology & Oncology
|
March 16, 2010
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
Song Dong, Ai-Lin Guo, Zhi-Hong Chen, et al.
Page
of 29
Search research articles
Search
Showing results (121-130 of 281) with videos related to
Sort By:
Page
of 29
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|
December 27, 2007
[MicroRNAs can be expressed in cardiomyocyte-like cells differentiated from human mesenchymal stem cells]
Zhi-xin Shan, Qiu-xiong Lin, Xi-yong Yu, et al.
European Journal of Pharmacology
|
August 13, 2021
A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC)
Hai-Yu Shen, Xiao-Qiang Li, Wen-Qiang Fan, et al.
Journal for Immunotherapy of Cancer
|
April 6, 2021
Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy
Chao Zhang, Kai Yin, Si-Yang Liu, et al.
Mikrochimica Acta
|
April 22, 2025
Development of an ultrasensitive magnetic bead-based non-competitive chemiluminescent immunoassay for 17β-estradiol in milk
Yi-Xian Liu, Bao-Zhu Jia, Xu-Chao Zhang, et al.
Plos One
|
October 12, 2012
A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy
Xu Chao, Zhuoli Zhang, Lili Guo, et al.
Nanoscale Advances
|
January 6, 2023
A nanofiber hydrogel derived entirely from ocean biomass for wound healing
Tian-Cai Sun, Bing-Yu Yan, Xu-Chao Ning, et al.
Journal of Cancer Research and Clinical Oncology
|
July 15, 2022
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes
Chang Lu, Xue-Wu Wei, Yi-Chen Zhang, et al.
Plos One
|
March 5, 2016
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines
Xiao-Yan Bai, Xu-Chao Zhang, Su-Qing Yang, et al.
JTO Clinical and Research Reports
|
July 5, 2022
Characteristics of and Treatment Strategies for Advanced <i>EGFR</i>-Mutant NSCLC With Concomitant <i>BRAF</i> Variations
Xue-Wu Wei, Jia-Yi Deng, Chong-Rui Xu, et al.
Journal of Hematology & Oncology
|
March 16, 2010
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
Song Dong, Ai-Lin Guo, Zhi-Hong Chen, et al.
Page
of 29